Lifitegrast Impurity 125 is a benzotriazolyl ester derivative of a dichloro-dihydroisoquinolinecarbonyl benzofuran compound, used as a pharmaceutical impurity reference standard for quality control in lifitegrast manufacturing.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2889431-14-3
N-(5-((Diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide
Pharmaceutical intermediate
Tert-Butyl 2-((4R,6S)-6-((E)-2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate
Rosuvastatin calcium intermediate
N-nitroso-tamsulosin
pharmaceutical reference standard
7-Nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro-(1,2,4)triazolo(4,3-a)pyrazine; 7-nitroso-3-(trifluoromethyl)-5H,6H,7H,8H-(1,2,4)triazolo(4,3-a)pyrazine
Nitrosamine impurity for sitagliptin
benzotriazol-1-yl 2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carboxylate
MKQYGFRVHFWWPY-UHFFFAOYSA-N
C1CN(CC2=CC(=C(C(=C21)Cl)C(=O)ON3C4=CC=CC=C4N=N3)Cl)C(=O)C5=CC6=C(C=C5)C=CO6